Nyxoah Archives | Page 8 of 15

Home / Posts tagged Nyxoah (Page 8)

Nyxoah to Participate in the Oppenheimer 33rd Annual Healthcare Conference

Mont-Saint-Guibert, Belgium, March 7 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Oppenheimer 33rd Annual Healthcare Conference, which takes place March 13-15, 2023, virtually. Olivier [...]

Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones

Mont-Saint-Guibert, Belgium, March 6 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company has completed all 115 implants in its DREAM U.S. pivotal study, submitted the first module in [...]

Nyxoah Announces Inaugural Investor & Analyst Meeting

Mont-Saint-Guibert, Belgium, Feb. 22 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will host its inaugural Investor & Analyst Meeting on March 23, 2023, from 4:00pm to 7:00pm [...]

Nyxoah Announces Inaugural Investor & Analyst Meeting

Mont-Saint-Guibert, Belgium, Feb. 21 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will host its inaugural Investor & Analyst Meeting on March 23, 2022, from 4:00pm to 7:00pm [...]

Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors

Mont-Saint-Guibert, Belgium, Jan. 9 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it has appointed Mr. Daniel Wildman as an Independent Director to its Board of Directors*. Mr. Wildman is [...]

Information on the Total Number of Voting Rights and Shares

Mont-Saint-Guibert (Belgium), Dec. 29 (Korea Bizwire) – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the belowinformation following the issue of new warrants. Share capital: EUR 4,440,069.16 Total number of securities carrying voting rights: 25,846,279 (all ordinary shares) Total number of voting rights (= denominator): 25,846,279 (all [...]

Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program

Mont-Saint-Guibert, Belgium, Dec. 22 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it has filed a $200 million shelf registration statement on Form F-3 (the “Registration Statement”) with the U.S. [...]

Nyxoah to Participate in the Piper Sandler 34th Annual Healthcare Conference

Mont-Saint-Guibert, Belgium, Nov. 17 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Piper Sandler 34th Annual Healthcare Conference, which takes place November 29-December 1, 2022, at the Lotte New [...]

Nyxoah Reports Third Quarter 2022 Financial and Operating Results

Mont-Saint-Guibert, Belgium, Nov. 8 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the quarter ended September 30, 2022. Third Quarter 2022 Financial and Operating Highlights Completed 110 of 115 implants in the DREAM U.S. [...]

Nyxoah Announces Change to Board of Directors

Mont-Saint-Guibert, Belgium, Oct. 24 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Raymond Cohen resigned as member of the board of directors of the Company effective October 18, 2022. About Nyxoah Nyxoah is a medical [...]